tiprankstipranks
Advertisement
Advertisement

Extendicare refreshes board as it deepens shift to health services

Story Highlights
  • Extendicare will add Josh Blair and Leslee Thompson to its board, while two long-serving directors retire at the upcoming AGM.
  • Major shareholder Samir Manji is expected to become chair, reinforcing Extendicare’s health services strategy with real estate and seniors care expertise.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Extendicare refreshes board as it deepens shift to health services

Claim 55% Off TipRanks

Extendicare ( (TSE:EXE) ) has provided an update.

Extendicare has announced proposed changes to its board, nominating Josh Blair and Leslee Thompson as new directors ahead of its April 16 annual shareholder meeting, while long-serving board members and key committee chairs Alan Torrie and Donna Kingelin will step down. The remaining seven directors will stand for re-election, and assuming shareholder approval, existing director and major shareholder Samir Manji is expected to become chair, bringing extensive real estate and seniors housing experience as the company continues to consolidate its shift toward a health services-focused model.

Blair, a former TELUS executive and current CEO of AI firm Impro.AI, adds digital, AI and capital markets expertise, while Thompson contributes deep health care leadership and quality standards experience from roles at Accreditation Canada and major hospital and health organizations. The refresh signals an effort to align board skills with Extendicare’s evolving strategy to expand access to care in the community, combining technology, real estate and clinical governance expertise to support its positioning as a leading seniors health services provider in Canada.

The most recent analyst rating on (TSE:EXE) stock is a Buy with a C$30.00 price target. To see the full list of analyst forecasts on Extendicare stock, see the TSE:EXE Stock Forecast page.

Spark’s Take on EXE Stock

According to Spark, TipRanks’ AI Analyst, EXE is a Outperform.

The score is supported primarily by strong technical momentum and a constructive earnings-call outlook highlighting improving operations and an accretive, strategically significant acquisition. The main constraints are only moderate underlying financial-quality consistency (thin margins and volatile free-cash-flow conversion) and a valuation that is not especially cheap, with added integration and leverage risk tied to the pending CBI transaction.

To see Spark’s full report on EXE stock, click here.

More about Extendicare

Extendicare Inc. is a Canadian seniors care provider offering long-term care, home health care, management services and group purchasing under the Extendicare, ParaMed, Extendicare Assist and SGP Purchasing Network brands. The company operates 99 long-term care homes, delivers about 14 million hours of home health services annually, and supplies purchasing services covering roughly 153,600 beds across Canada.

With a workforce of approximately 23,000 employees and a further 5,000 managed through joint ventures, Extendicare focuses on serving the growing seniors population. Its business model emphasizes health services and community-based care, aiming to deliver quality support to older adults wherever they reside, from institutional long-term care to home and community settings.

Average Trading Volume: 309,860

Technical Sentiment Signal: Buy

Current Market Cap: C$2.56B

For a thorough assessment of EXE stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1